Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies.

FIRES NORSE drug-resistance epilepsy syndromes inflammatory epilepsies status epilepticus

Journal

Neuropsychiatric disease and treatment
ISSN: 1176-6328
Titre abrégé: Neuropsychiatr Dis Treat
Pays: New Zealand
ID NLM: 101240304

Informations de publication

Date de publication:
2019
Historique:
received: 25 02 2019
accepted: 13 06 2019
entrez: 3 8 2019
pubmed: 3 8 2019
medline: 3 8 2019
Statut: epublish

Résumé

Febrile infection-related epilepsy syndrome (FIRES) is a rare catastrophic epileptic encephalopathy with a yet undefined etiology, affecting healthy children. It is characterized by acute manifestation of recurrent seizures or refractory status epilepticus preceded by febrile illness, but without evidence of infectious encephalitis. To date, the absence of specific biomarkers poses a significant diagnostic challenge; nonetheless, early diagnosis is very important for optimal management. FIRES is mostly irreversible and its sequelae include drug-resistant epilepsy and neuropsychological impairments. The treatment of FIRES represents a significant challenge for clinicians and is associated with low success rates. Early introduction of ketogenic diet seems to represent the most effective and promising treatment. This review aims to highlight the most recent insights on clinical features, terminology, epidemiology, pathogenesis, diagnostic challenges and therapeutic options.

Identifiants

pubmed: 31371963
doi: 10.2147/NDT.S177803
pii: 177803
pmc: PMC6635824
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1897-1903

Déclaration de conflit d'intérêts

All of the authors declare that they have no conflicts of interest in this work.

Références

Epilepsia. 2001 Nov;42(11):1461-7
pubmed: 11879350
Seizure. 2003 Sep;12(6):379-87
pubmed: 12915084
Neuropediatrics. 2004 Aug;35(4):250-2
pubmed: 15328567
Ann Acad Med Singapore. 2005 Aug;34(7):417-20
pubmed: 16123813
Epilepsy Res. 2006 Apr;69(1):67-79
pubmed: 16469483
Acta Neurol Scand. 2010 Apr;121(4):251-6
pubmed: 20028339
Epilepsia. 2010 Jul;51(7):1225-35
pubmed: 20196775
Epilepsia. 2010 Jul;51(7):1323-8
pubmed: 20345937
Epilepsy Res. 2010 Oct;91(2-3):111-22
pubmed: 20709500
Epilepsia. 2010 Oct;51(10):2033-7
pubmed: 20813015
Eur J Neurol. 2011 Jul;18(7):952-61
pubmed: 21087361
Lancet Neurol. 2011 Jan;10(1):99-108
pubmed: 21163447
Epilepsia. 2011 Nov;52(11):1956-65
pubmed: 21883180
Brain. 2011 Oct;134(Pt 10):2802-18
pubmed: 21914716
Brain Dev. 2012 Apr;34(4):302-7
pubmed: 21959126
Epilepsia. 2011 Oct;52 Suppl 8:6-7
pubmed: 21967349
Epilepsia. 2011 Oct;52 Suppl 8:67-9
pubmed: 21967368
Epilepsia. 2011 Nov;52(11):e185-9
pubmed: 22004046
Epilepsy Res. 2012 Jun;100(1-2):194-8
pubmed: 22386634
Pediatr Neurol. 2012 Jun;46(6):375-81
pubmed: 22633633
Neuropediatrics. 2012 Aug;43(4):209-16
pubmed: 22911482
Epilepsia. 2012 Sep;53 Suppl 4:58-62
pubmed: 22946722
Dev Med Child Neurol. 2012 Dec;54(12):1144-8
pubmed: 23066759
Epilepsia. 2013 Jun;54(6):1036-45
pubmed: 23551014
Ann Neurol. 2013 Jul;74(1):1-3
pubmed: 23686675
Continuum (Minneap Minn). 2013 Jun;19(3 Epilepsy):767-94
pubmed: 23739110
Epilepsia. 2013 Sep;54 Suppl 6:54-6
pubmed: 24001074
Epilepsia. 2014 Jun;55(6):791-802
pubmed: 24854329
Neuropharmacology. 2015 Sep;96(Pt A):70-82
pubmed: 25445483
Semin Pediatr Neurol. 2014 Sep;21(3):221-5
pubmed: 25510944
Semin Pediatr Neurol. 2014 Sep;21(3):232-7
pubmed: 25510946
Semin Pediatr Neurol. 2014 Dec;21(4):263-74
pubmed: 25727508
Epilepsy Res. 2015 May;112:100-13
pubmed: 25847345
Semin Neurol. 2015 Jun;35(3):259-68
pubmed: 26060905
Epilepsia. 2016 Jan;57(1):e7-e11
pubmed: 26592968
Adv Exp Med Biol. 2015;888:41-70
pubmed: 26663178
Lancet Neurol. 2016 Mar;15(3):270-8
pubmed: 26724101
J Clin Neurosci. 2016 Apr;26:89-94
pubmed: 26822381
Curr Opin Neurol. 2016 Apr;29(2):151-7
pubmed: 26886357
Brain Dev. 2016 Sep;38(8):772-6
pubmed: 26906012
J Neurol. 2016 Apr;263(4):799-806
pubmed: 26914931
Dev Med Child Neurol. 2016 Nov;58(11):1180-1192
pubmed: 27242065
Seizure. 2016 Oct;41:62-5
pubmed: 27475280
J Child Neurol. 2017 Jan;32(1):35-40
pubmed: 27655472
Ann Neurol. 2016 Dec;80(6):939-945
pubmed: 27770579
Neuropediatrics. 2017 Feb;48(1):5-18
pubmed: 27919115
Seizure. 2017 Apr;47:34-41
pubmed: 28284046
Child Neurol Open. 2015 Mar 23;2(1):2329048X14550067
pubmed: 28503584
Epilepsia. 2017 Jul;58 Suppl 3:7-10
pubmed: 28675561
Neurodiagn J. 2017;57(3):224-233
pubmed: 28898171
Eur J Paediatr Neurol. 2018 Jan;22(1):182-185
pubmed: 29203057
Seizure. 2018 Feb;55:66-69
pubmed: 29414137
Epilepsia. 2018 Apr;59(4):745-752
pubmed: 29476535

Auteurs

Domenico Serino (D)

Department of Child Neurology, Royal Aberdeen Children's Hospital, Aberdeen, UK.

Marta Elena Santarone (ME)

Department of Neuroscience, Bambino Gesù Children's Hospital, Rome, Italy.

Davide Caputo (D)

Neurology Unit, Neuroscience Department, San Paolo Hospital, Milan, Italy.

Lucia Fusco (L)

Department of Neuroscience, Bambino Gesù Children's Hospital, Rome, Italy.

Classifications MeSH